Challenges in the diagnosis of primary cutaneous CD30
+
anaplastic large-cell lymphoma
Br J Dermatol
.
2020 Jan;182(1):233-234.
doi: 10.1111/bjd.18328.
Epub 2019 Sep 9.
Authors
G Dobos
1
2
3
,
M Battistella
2
4
,
F Jouenne
2
5
,
S Mourah
2
5
,
M D Vignon-Pennamen
3
,
C Ram-Wolff
1
,
F Herms
1
,
J N Dauendorffer
1
,
J Rivet
3
,
J M Cayuela
6
,
D Bouaziz
1
2
,
P Brice
7
,
C Lebbé
1
2
,
M Bagot
1
2
,
A de Masson
1
2
Affiliations
1
Department of Dermatology, APHP, Saint-Louis Hospital, Paris, France.
2
Université de Paris, INSERM U976, Paris, France.
3
Skin Cancer Centre, Charité-Universitätsmedizin Berlin, Germany.
4
Department of Pathology, APHP, Saint-Louis Hospital, Paris, France.
5
Department of Pharmacogenomics, APHP, Saint-Louis Hospital, Paris, France.
6
Laboratory of Hematology, APHP, Saint-Louis Hospital, Paris, France.
7
Department of Hmatological Oncology, APHP, Saint-Louis Hospital, Paris, France.
PMID:
31278742
DOI:
10.1111/bjd.18328
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Aged
Humans
Ki-1 Antigen
Lymphoma, Large-Cell, Anaplastic* / diagnosis
Male
Skin
Skin Neoplasms* / diagnosis
Substances
Ki-1 Antigen